collaboration
Sarepta Licenses Clinical, Preclinical siRNA Candidates From Arrowhead, Enters Discovery Deal
Sarepta will pay Arrowhead Pharmaceuticals $500 million upfront, make a $325 million equity investment, plus pay $250 million over five years, and more.
Advanced Genomics APAC, 3BIGS Partner on Cancer Testing in Asia-Pacific
The firms will bring together Advanced Genomics APAC's genomic profiling workflow and 3BIGS's bioinformatics capabilities.
Caris Life Sciences Expands Access to Urologic Cancer Tests Through Deal With Lumea
The firms agreed to make Caris' whole-exome and whole-transcriptome sequencing tests available through Lumea's BxLink digital pathology software.
Mainz Biomed, Thermo Fisher Scientific to Develop Colorectal Cancer Screening Test
The collaboration will enable Mainz Biomed to harness Thermo Fisher’s resources to develop a new version of its mRNA-based colorectal cancer screening test.
CHOP, Brazilian National Cancer Institute to Bring Automated Cell Therapy Manufacturing to Brazil
The institutions will use a $4 million grant to launch a Rio de Janeiro-based center equipped with an automated closed-system CAR T-cell therapy platform.